Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies

被引:145
作者
Shah, Nirav N. [1 ]
Maatman, Theresa [2 ]
Hari, Parameswaran [1 ]
Johnson, Bryon [1 ]
机构
[1] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
关键词
CAR-T; antigen escape; B-cell NHL; B-cell ALL; immunotherapy; ANTIGEN ESCAPE; RECEPTOR; EFFICACY; RESISTANCE; LEUKEMIA;
D O I
10.3389/fonc.2019.00146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chimeric antigen receptor (CAR) modified T cell therapy has revolutionized the treatment of relapsed and refractory hematological malignancies. Through targeting of the CD19 antigen on B cells durable remissions have been achieved in patients with B cell non-Hodgkin lymphoma and acute lymphoblastic lymphoma. Despite impressive responses, multiple escape mechanisms to evade CAR-T cell therapy have been identified, among which the most common is loss of the target antigen. In this review we will highlight outcomes to date with CD19 CAR-T cell therapy, describe the current limitations of single targeted CAR-T therapies, review identified tumor escape mechanisms, and lastly discuss novel strategies to overcome resistance via multi-targeted CAR-T cells.
引用
收藏
页数:7
相关论文
共 46 条
[1]  
[Anonymous], 2018, BLOOD S1, DOI [DOI 10.1182/blood-2018-99-110142, DOI 10.1182/BLOOD-2018-99-110142]
[2]  
[Anonymous], 2017, BLOOD S1
[3]   Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System [J].
Avanzi, Mauro P. ;
Yeku, Oladapo ;
Li, Xinghuo ;
Wijewarnasuriya, Dinali P. ;
van Leeuwen, Dayenne G. ;
Cheung, Kenneth ;
Park, Hyebin ;
Purdon, Terence J. ;
Daniyan, Anthony F. ;
Spitzer, Matthew H. ;
Brentjens, Renier J. .
CELL REPORTS, 2018, 23 (07) :2130-2141
[4]   CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum [J].
Bagashev, Asen ;
Sotillo, Elena ;
Tang, Chih-Hang Anthony ;
Black, Kathryn L. ;
Perazzelli, Jessica ;
Seeholzer, Steven H. ;
Argon, Yair ;
Barrett, David M. ;
Grupp, Stephan A. ;
Hu, Chih-Chi Andrew ;
Thomas-Tikhonenko, Andrei .
MOLECULAR AND CELLULAR BIOLOGY, 2018, 38 (21)
[5]   FCγ Chimeric Receptor-engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance [J].
Caratelli, Sara ;
Sconocchia, Tommaso ;
Arriga, Roberto ;
Coppola, Andrea ;
Lanzilli, Giulia ;
Lauro, Davide ;
Venditti, Adriano ;
Del Principe, Maria Ilaria ;
Buccisano, Francesco ;
Maurillo, Luca ;
Ferrone, Soldano ;
Sconocchia, Giuseppe .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[6]   Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes [J].
Clemenceau, Beatrice ;
Congy-Jolivet, Nicolas ;
Gallot, Geraldine ;
Vivien, Regine ;
Gaschet, Joelle ;
Thibault, Gilles ;
Vie, Henri .
BLOOD, 2006, 107 (12) :4669-4677
[7]   T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells [J].
D'Aloia, Maria Michela ;
Caratelli, Sara ;
Palumbo, Camilla ;
Battella, Simone ;
Arriga, Roberto ;
Lauro, Davide ;
Palmieri, Gabriella ;
Sconocchia, Giuseppe ;
Alimandi, Maurizio .
CYTOTHERAPY, 2016, 18 (02) :278-290
[8]   Cancer immunoediting: from immunosurveillance to tumor escape [J].
Dunn, GP ;
Bruce, AT ;
Ikeda, H ;
Old, LJ ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2002, 3 (11) :991-998
[9]   Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells [J].
Evans, Andrew G. ;
Rothberg, Paul G. ;
Burack, W. Richard ;
Huntington, Scott F. ;
Porter, David L. ;
Friedberg, Jonathan W. ;
Liesveld, Jane L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (02) :205-209
[10]   CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis [J].
Fischer, Jeannette ;
Paret, Claudia ;
El Malki, Khalifa ;
Alt, Francesca ;
Wingerter, Arthur ;
Neu, Marie A. ;
Kron, Bettina ;
Russo, Alexandra ;
Lehmann, Nadine ;
Roth, Lea ;
Fehr, Eva-M. ;
Attig, Sebastian ;
Hohberger, Alexander ;
Kindler, Thomas ;
Faber, Joerg .
JOURNAL OF IMMUNOTHERAPY, 2017, 40 (05) :187-195